Nature Communications · 2022 · 43 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryProdrug DesignCluster ChemistryLigand BindingRedox-activated ProdrugsAcidic Tumor MicroenvironmentMolecular Metal ClustersNoble Metal ClustersRedox-activated Anticancer ProdrugsThiolate-protected Gold ClustersTransition Metal Clusters
Medicinal applications of gold complexes have recently attracted attention due to their innovative antitumor mechanisms. In this work, two hypercoordinated carbon-centered gold clusters PAA4 and PAA5 are quantitatively synthesized by an intramolecular 6-exo-dig cyclization of polymetalated precursors. The on-bench and in vitro experimental studies demonstrate that the characteristic hypercarbon-tetragold(I) multi-center bonding in PAA4 and PAA5 not only guarantees their stability under common physiological conditions, but also facilitates a glutathione (GSH)-triggered prompt and synergetic release of active Au(I) ions in the GSH-overexpressed and acidic microenvironment of human bladder cancer EJ cells. The instantly massive release of coordination unsaturated Au(I) ions causes the efficient inhibition of thioredoxin reductases and then induces a rapid pro-oxidant response, consequently causing the occurrence of accelerated ferroptosis of EJ cells. As a result, these hypercarbon-centered gold(I) cluster prodrugs show high cytotoxicity to bladder cancer cell lines and thus exhibit a significant inhibition effect towards bladder tumors in vivo. Correlation of the synergetic domino dissociation of carbon-polymetal multi-center bonding in metal clusters with the accelerated ferroptosis of cancer cells provides a strategy for metallo-prodrugs and opens a broader prospect for the biological application of metal cluster compounds.
29
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell · 2012 · 18.1K citations · Full text
Pekka Pyykkö · Angewandte Chemie International Edition · 2004 · 1.9K citations
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Chao Mao, Xiaoguang Liu, Yilei Zhang et al. · Nature · 2021 · 1.8K citations · Full text
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan et al. · Nature · 2017 · 1.7K citations
Medicine, Oncology, Pharmacology +11